Biofil Chemicals & Pharmaceuticals Stock Performance
as on September 2, 2026 at 9:31 pm IST
Day's Low
Day's High
₹31.55₹32.80
1.25%
Downside
2.66%
Upside

52 Week's Low
52 Week's High
₹25.60₹46.34
19.87%
Downside
45.04%
Upside

Biofil Chemicals & Pharmaceuticals share price movements today
- Previous Close
- ₹32.15
- Open
- ₹32.60
- Volume
- 4,881.00
- Upper Circuit
- ₹38.58
- Lower Circuit
- ₹25.72
- Day's Low - High
- ₹31.55 - ₹32.80
- 52 Week Low - High
- ₹25.60 - ₹46.34
Biofil Chemicals & Pharmaceuticals Historical Returns
- 1 Month Return
- -2.78 %
- 3 Month Return
- -6.46 %
- 1 Year Return
- -26.18 %
- 3 Year Return
- -34.32 %
- 5 Year Return
- -49.09 %
Biofil Chemicals & Pharmaceuticals Fundamentals
as on September 2, 2026 at 4:01 pm IST
Market Cap
₹52.31 Cr
Return on Equity (ROE)
-1.14
PE Ratio (TTM)
0Return on capital employed (ROCE)
1.26
Industry PE ratio
-
Beta (LTM)
0.86
P/B Ratio
1.95
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-95.44
EPS (TTM)
0Book Value
0Biofil Chemicals & Pharmaceuticals Technical Analysis
Track how Biofil Chemicals & Pharmaceuticals technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0.02 | Bullish |
CCI (20) | 665.31 | |
RSI (14) | 88.71 | |
Momentum (10) | 0.16 | Bullish |
ADI (14) | 98.58 | Bullish |
Ultimate Oscillator (7,14,28) | 28.12 |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 31.74 | Bullish |
EMA (20) | 31.75 | Bullish |
VWMA (20) | 31.75 | Bullish |
SMA (50) | 31.75 | Bullish |
EMA (50) | 31.74 | Bullish |
SMA (200) | 31.75 | Bullish |
EMA (200) | 31.82 | Bullish |
KAMA (200) | 31.79 | Bullish |
DEMA (200) | 31.63 | Bullish |
Biofil Chemicals & Pharmaceuticals Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Biofil Chemicals & Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 52.31 | -9.82% | 0.00 | 2 | 28 | |
| BUY | 28,384.34 | 2.44% | 0.71 | -326 | 8,869 | |
| NA | 17,292.50 | 23.38% | 0.00 | 187 | 2,275 | |
| BUY | 14,458.07 | 7.55% | 0.73 | 397 | 8,279 | |
| NA | 212.79 | 28.7% | 0.95 | -14 | 125 |
Biofil Chemicals & Pharmaceuticals Stock’s Investor Sentiment and Interest
Search interest for Biofil Chemicals & Pharmaceuticals Ltd Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:15% versus previous 30 day period
Biofil Chemicals & Pharmaceuticals Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Biofil Chemicals & Pharmaceuticals Ltd Annual Profit & Loss
Figures in Rupees Crores
Biofil Chemicals & Pharmaceuticals Ltd Cash Flow
Figures in Rupees Crores
Biofil Chemicals & Pharmaceuticals Corporate Actions
View detailed summary of the earnings and dividend history of Biofil Chemicals & Pharmaceuticals.
Biofil Chemicals & Pharmaceuticals Ltd Earnings Results
Biofil Chemicals & Pharmaceuticals Ltd’s net profit fell -95.44% since last year same period to ₹0.11Cr in the Q1 2026-2027. On a quarterly growth basis, Biofil Chemicals & Pharmaceuticals Ltd has generated -47.62% fall in its net profits since last 3-months.
Read More about Earnings Results
Insights on Biofil Chemicals & Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers

In the last 1 year, Divis Laboratories Ltd has given 49.7% return, outperforming this stock by 75.9%
NO EFFECTAgainst Peers

In the last 3 years, Torrent Pharmaceuticals Ltd has given 171.8% return, outperforming this stock by 206.1%
NO EFFECTRetail Holding Unchanged

Retail Investor holdings remained unchanged at 53.13% of holdings in Jun 2026 quarter
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 46.79% of holdings in Jun 2026 quarter
NEGATIVE IMPACTPrice Dip

In the last 3 years, BIOFILCHEM stock has moved down by -34.3%
About Biofil Chemicals & Pharmaceuticals Ltd
Revenue: ₹12.35Cr as on June 2026 (Q1 FY27)
Net Profit: ₹0.11Cr as on June 2026 (Q1 FY27)
Listing date: 12 Jun, 1996
Chairperson Name: Ramesh Shah
| Organisation | Biofil Chemicals & Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| CEO | Ramesh Shah |
| E-voting on shares | Click here to vote |
FAQs
What is Biofil Chemicals & Pharmaceuticals share price today?
Biofil Chemicals & Pharmaceuticals share price today stands at ₹31.95 as on at the close of the market. Biofil Chemicals & Pharmaceuticals share today touched a day high of ₹32.8 and a low of ₹31.55.
What is the 52 week high and 52 week low range for Biofil Chemicals & Pharmaceuticals share?
Biofil Chemicals & Pharmaceuticals touched a 52 week high of ₹46.34 and a 52 week low of ₹25.6. Biofil Chemicals & Pharmaceuticals share price today i.e. is closed at ₹31.95, which is -31.05% down from its 52 week high and 24.80% up from its 52 week low.
What is Biofil Chemicals & Pharmaceuticals's market capitalisation today?
Biofil Chemicals & Pharmaceuticals market capitalisation is ₹52.31 Cr as on .
How to buy Biofil Chemicals & Pharmaceuticals shares?
To buy Biofil Chemicals & Pharmaceuticals shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for BIOFILCHEM or Biofil Chemicals & Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Biofil Chemicals & Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Biofil Chemicals & Pharmaceuticals trading volume today?
Biofil Chemicals & Pharmaceuticals trading volume is 4,881.00 as on . This means that 4,881.00 shares of Biofil Chemicals & Pharmaceuticals were bought and sold on the stock market during today's trading session.